News from ACC.25: Dapa-TAVI, dapagliflozin, elderly TAVI pts

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
ACC.25 – Wayne Batchelor discusses the results of Dapa-TAVI. Compared with standard care, dapagliflozin reduced worsening of HF in elderly patients with aortic stenosis who underwent TAVI and were at high risk for HF events.
Educational information
This video was recorded during the ACC.25 Scientific Session Chicago, IL, USA.
Faculty
Wayne Batchelor is President of the Medicine Service Line at Inova Health System in Fairfax, VA, USA. He is also a professor at Duke University in Durham, NC, USA and chair of the ACC's Interventional Council.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 18 April 2025
Read our summary of Dapa-TAVI
The findings of this study were simultaneously published in N Engl J Med.
The information and data provided in this program were updated and correct at the time of its development, but may be subject to change.

Recommended

Details

Presenters

Overview
ACC.25 – Wayne Batchelor discusses the results of Dapa-TAVI. Compared with standard care, dapagliflozin reduced worsening of HF in elderly patients with aortic stenosis who underwent TAVI and were at high risk for HF events.
Educational information
This video was recorded during the ACC.25 Scientific Session Chicago, IL, USA.
Faculty
Wayne Batchelor is President of the Medicine Service Line at Inova Health System in Fairfax, VA, USA. He is also a professor at Duke University in Durham, NC, USA and chair of the ACC's Interventional Council.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 18 April 2025
Read our summary of Dapa-TAVI
The findings of this study were simultaneously published in N Engl J Med.
The information and data provided in this program were updated and correct at the time of its development, but may be subject to change.

Dapagliflozin reduces worsening HF in elderly TAVI patients